Aprea Therapeutics, Inc. (APRE) stock
APRENasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.46+0.01 (+2.60%)
Close on Nov 18, 2026Market cap $5.85MP/E –Yield –
Aprea Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Aprea Therapeutics's market cap was $5.51M on Nov 11, 2026, against $7.53M a year earlier. Over the last 5 years it ranged from $4.76M to $61.30M, with a median of $14.37M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.51M | +8.0% |
| 2025 | Dec 31, 2025 | $5.10M | -71.5% |
| 2024 | Dec 31, 2024 | $17.88M | +1.8% |
| 2023 | Dec 29, 2023 | $17.56M | +1.6% |
| 2022 | Dec 30, 2022 | $17.29M | -71.8% |
| 2021 | Dec 31, 2021 | $61.30M | -41.2% |
| 2020 | Dec 31, 2020 | $104.24M | +92.2% |
| 2019 | Dec 31, 2019 | $54.23M | – |
See a number that looks wrong?